Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS

PHASE3CompletedINTERVENTIONAL
Enrollment

209

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Restless Legs Syndrome (RLS)
Interventions
DRUG

Injectafer

OTHER

Placebo

Trial Locations (19)

20759

Ctr for Brain & Neuro Care, LLC, Fulton

27405

Guilford Neurologic Associates, Greensboro

29307

Saad Upstate Neurology, Spartanburg

29707

Metrolina Neurological Associates, Old Point Station

33169

Elite Research Institute, Miami

33428

Neurology Offices of South FL, Boca Raton

36608

Coastal Clinical Research, Inc., Mobile

37604

Tri-State Mountain Neurology Associates, Johnson City

40509

Central Kentucky Research Assoc., Inc., Lexington

71301

Neuromedical Clinical of Central Louisiana, Alexandria

77058

Egret Bay Neurology, Houston

89119

Desert Neurology, Las Vegas

89128

Neurology Center of Las Vegas, Las Vegas

91950

Synergy San Diego, National City

92270

Desert Valley Research, Rancho Mirage

92374

Anderson Clinical Research, Redlands

98104

The Polyclinic, Madison Center, Seattle

66214-1505

MidAmmerica Neuroscience Institute, Lenexa

02114

Massachusetts General Hospital, Sleep Disorders Clinical Research Program, Boston

Sponsors
All Listed Sponsors
lead

American Regent, Inc.

INDUSTRY

NCT02397057 - Placebo-Controlled Study to Investigate the Efficacy & Safety of Injectafer in the Treatment of RLS | Biotech Hunter | Biotech Hunter